Dr. Ghada A. Soliman

powered by
COS Expertise®
Western Michigan University
College of Education
Family and Consumer Sciences
Dietetics-Nutrition
Assistant ProfessorAppointed: 2009
University of Michigan
Medical School
Metabolism, Endocrinology, and Diabetes
Research Assistant ProfessorAppointed: 2004
Professional Headshot of Ghada A. Soliman

Mailing Address

1903 W. Michigan Ave
3222 Kohrman Hall
Kalamazoo, Michigan 49008
United States

Contact Information

Phone: (269) 387-3722
Fax: (269) 387-3353
ghada.soliman@wmich.edu

Qualifications

Ph.D., University of Arizona, Nutritional Biochemistry, 1994.
M.D., Cairo University, 1987.

Expertise and Research Interests

Research Interest:
Lipids and Lipoprotein Metabolism
Hyperlipidemia
Rapamycin-induced Hypertriglyceridemia
Regulation of Mammalian Target of Rapamycin (mTOR)
Impact of mTOR on Insulin Signal Transduction

Other Expertise

Post Doctoral Fellow-Baylor College of Medicine - 1996-2002
Dietetic Internship - University of Michigan - 2008-2009

Keywords

COS Keywords:

Arteriosclerosis or Atherosclerosis, Biochemistry, Lipids, Immunosuppression, Lipid Metabolism, Lipoproteins, Signal Transduction.

Additional Terms:

Hyperlipidemia, Immunosuppression, Lipid and Lipoprotein Metabolism, MTOR and Signal Transduction.

Memberships

American Diabetes Association
American Dietetic Association
American Institute of Nutrition (AIN)

Honors and Awards

2002-2006, KO1 Career Development Award, NIH-NIDDK
2001, Reviewer, Journal of Nutrition
1996-1998, Postdoctoral Fellowship, USDA, Baylor College of Medicine
1991, Outstanding Graduate Student Paper of Original Research, American Institute of Nutrition

Previous Positions

2002-2004, Assistant Professor, Baylor College of Medicine, Medicine, Medicine, Atherosclerosis and Vascular Biology
2000-2002, Post-doctoral fellow, Baylor College of Medicine, Medicine, Atherosclerosis and Vascular Biology
1998-2000, Research Associate, Baylor College of Medicine, Surgery
1996-1998, Post-doctoral fellow, Baylor College of Medicine, Children Nutrition Research Center, Pediatrics
1995-1996, Postdoctoral Associate, University of Arizona, Nutritional Sciences

Funding Received

  • Grant in Aid- 0750060Z: Role of mTOR in Triglyceride and Free Fatty Acid Metabolism, 2007 to 2008.
  • KO1-DK 60654: Molecular Signaling of Rapamycin Induced Hyperlipidemia, 2002 to 2006.

Publications

  • Acosta-Jaquez HA, Keller JA, Foster KG, Ekim B, Soliman GA, Feener EP, Ballif BA, Fingar DC (Aug 2009) Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth., Molecular and cellular biology, 29 (15), 4308-24 Abstract
  • Soliman GA, Ishida-Takahashi R, Gong Y, Jones JC, Leshan RL, Saunders TL, Fingar DC, Myers MG (Oct 2007) A simple qPCR-based method to detect correct insertion of homologous targeting vectors in murine ES cells., Transgenic research, 16 (5), 665-70 Abstract
  • Aggarwal D, Fernandez ML, Soliman GA (Jun 2006) Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs., Metabolism: clinical and experimental, 55 (6), 794-802 Abstract
  • Aggarwal D, Freake HC, Soliman GA, Dutta A, Fernandez ML (2006) Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism., Lipids in health and disease, 5, 22 Abstract
  • Soliman GA (Jun 2005) The mammalian target of rapamycin signaling network and gene regulation., Current opinion in lipidology, 16 (3), 317-23 Abstract
  • JD Morrisett, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Oppermann S, and Kehan B., Effects of Sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients, Journal of Lipid Research, 43, 1170-1180, 16 Aug 2002
  • Morrisett D.J., Hoogeveen R., Abdel-Fattah G., Pownall H., Ballantyne C., Opekun A., Jaffe J., Oppermann S., Kahan BD., Effects of Rapamycin On Free Fatty Acid Metabolism In Renal Transplant Patients, Arteriosclerosis, Thrombosis, and Vascular Biology, 21(Abstract), 654:67, April 2001
  • Abdel-Fattah G, Yoffe B, Krishnan B, Khaoustov V, Itani K, MDM2/p53 protein expression in the development of colorectal adenocarcinoma, Journal of Gastrointestinal Surgery, 4(1), 109-14, 2000 Abstract
  • Abdel-Fattah G, Fernandez ML, McNamara DJ, Regulation of very low density lipoprotein apo B metabolism by dietary fat saturation and chain length in the guinea pig, Lipids, 33(1), 23-31, Jan 1998 Abstract
  • Fernandez ML, Vergara-Jimenez M, Conde K, Behr T, Abdel-Fattah G, Regulation of apolipoprotein B-containing lipoproteins by dietary soluble fiber in guinea pigs, American Journal of Clinical Nutrition, 65(3), 814-22, March 1997 Abstract
  • Fernandez ML, Vergara-Jimenez M, Conde K, Abdel-Fattah G, Dietary carbohydrate type and fat amount alter VLDL and LDL metabolism in guinea pigs, Journal of Nutrition, 126(10), 2494-504, October 1996 Abstract
  • Abdel-Fattah G, Fernandez ML, McNamara DJ, Regulation of guinea pig very low density lipoprotein secretion rates by dietary fat saturation, Journal of Lipid Research, 36(6), 1188-98, June 1995 Abstract
  • Fernandez ML, Abdel-Fattah G, McNamara DJ, Differential effects of simple vs. complex carbohydrates on VLDL secretion rates and HDL metabolism in the guinea pig, Biochimica Et Biophysica Acta, 1256(1), 31-8, 1995 Abstract
  • Fernandez ML, Abdel-Fattah G, McNamara DJ, Dietary fat saturation modifies the metabolism of LDL subfractions in guinea pigs, Arteriosclerosis and Thrombosis, 13(10), 1418-28, October 1993 Abstract
  • Abdel-Fattah G., B. Watzl, D. Haung and R.R. Watson., Beta Carotene in vitro stimulates interleukin 1 alpha and tumor necrosis factor alpha in human peripheral blood mononuclear cells, Nutrition Research, 13, 863-871, 1993

Profile Details

Last Verified: 8/27/2009

COS Expertise ID #338265
Reference this profile directly: http://myprofile.cos.com/ghadaa